Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Gastroenterology Clinics of North America|November 28, 2017
Diet as a Therapeutic Option for Adult Inflammatory Bowel DiseaseSamir Kakodkar, Ece A MutluExpert Opinion on Investigational Drugs|February 28, 2002
New developments in the treatment of inflammatory bowel diseaseEce A Mutlu, Ashkan Farhadi, Ali KeshavarzianAmerican Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Prevention and treatment of gastrointestinal complications in patients on mechanical ventilationGökhan M Mutlu, Ece A Mutlu, Phillip FactorMedical Hypotheses|January 31, 2019
Collagenous colitis development occurs after long standing mucosal healing in IBD with TNF-α inhibitors, and could be due to exaggerated healing response from excess TNF-α inhibitionRahoma E Saad, Rima Shobar, Ece A MutluScandinavian Journal of Gastroenterology|May 24, 2006
Hyperalbuminemia and elevated transaminases associated with high-protein dietEce A Mutlu, Ali Keshavarzian, Gökhan M MutluChemistry & Biodiversity|May 22, 2010
Quantitative assessment of the human gut microbiome using multitag pyrosequencingPatrick Gillevet, Masoumeh Sikaroodi, Ali Keshavarzian, et al.Physiological Genomics|July 16, 2017
Relationships between gastrointestinal microbiota and blood group antigensAnuhya Gampa, Phillip A Engen, Rima Shobar, et al.World Journal of Gastroenterology|June 11, 2014
TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: a case report and literature reviewRuwaida Ben Musa, Lydia Usha, John Hibbeln, et al.The American Journal of Medicine|August 5, 2006
Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapyGökhan M Mutlu, Ece A Mutlu, Amy Bellmeyer, et al.Journal of Clinical Gastroenterology|March 22, 2002
Intestinal permeation and gastrointestinal diseaseMark T DeMeo, Ece A Mutlu, Ali Keshavarzian, et al.Pageof 4